jintropin

Botanicalexperimental

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years. — Wikipedia

Clinical trial activity

2 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2006 (NCT01342146)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • jintropin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07260500Phase 2Nov 11, 2025GeneScience Pharmaceuticals Co., Ltd.
NCT01342146Phase 2May 1, 2006Capital Medical University, Fudan University, GeneScience Pharmaceuticals Co., Ltd., Huazhong University of Science and Technology, Sun Yat-Sen University
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GeneScience Pharmaceuticals Co., Ltd.For profit2212006
Capital Medical UniversityAcademic/Hospital1012006
Fudan UniversityAcademic/Hospital1012006
Huazhong University of Science and TechnologyAcademic/Hospital1012006
Sun Yat-Sen UniversityAcademic/Hospital1012006
5 organizations
Page 1 / 1